Xtrackers MSCI World Ex Usa UCITS ETF (LON:EXUS)
London
· Delayed Price · Currency is GBP · Price in USD 36.78
-0.30 (-0.81%)
Jul 15, 2025, 4:35 PM BST
12.26% (1Y)
| Assets | 3.28B |
| Expense Ratio | 0.15% |
| PE Ratio | 16.87 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +12.33% |
| Volume | 26,054 |
| Open | 37.16 |
| Previous Close | 37.08 |
| Day's Range | 36.73 - 37.18 |
| 52-Week Low | 29.12 |
| 52-Week High | 37.49 |
| Beta | 0.79 |
| Holdings | 782 |
| Inception Date | Mar 6, 2024 |
About EXUS
The fund is passively managed. DESCRIPTION OF INDEX: The aim is for your investment to track the performance, before fees and expenses, of the MSCI World ex USA Index (index) which is designed to reflect the performance of companies from global developed markets, excluding the United States of America.
Asset Class Equity
Category Total Market
Stock Exchange London Stock Exchange
Ticker Symbol EXUS
Provider Xtrackers
Index Tracked MSCI World ex USA
Performance
EXUS had a total return of 12.33% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.95%.
Top 10 Holdings
11.33% of assets| Name | Symbol | Weight |
|---|---|---|
| SAP SE | SAP | 1.49% |
| ASML Holding N.V. | ASML | 1.47% |
| Nestlé S.A. | NESN | 1.22% |
| Novartis AG | NOVN | 1.08% |
| Roche Holding AG | ROG | 1.07% |
| Novo Nordisk A/S | NOVO.B | 1.05% |
| AstraZeneca PLC | AZN | 1.01% |
| HSBC Holdings plc | HSBA | 1.00% |
| Shell plc | SHEL | 0.98% |
| Commonwealth Bank of Australia | CBA | 0.95% |